Cargando…
Response to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
Autor principal: | Saba, Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511082/ https://www.ncbi.nlm.nih.gov/pubmed/35856458 http://dx.doi.org/10.1111/jvim.16490 |
Ejemplares similares
-
ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study
por: Saba, Corey, et al.
Publicado: (2022) -
Letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
por: Rishniw, Mark, et al.
Publicado: (2022) -
Response from Co‐Editor‐in‐Chiefs to letter regarding “ALVAC‐fIL2, a feline interleukin‐2 immunomodulator, as a treatment for sarcoids in horses: A pilot study”
por: DiBartola, Stephen P., et al.
Publicado: (2022) -
Sarcoid Here, Sarcoid There, Sarcoid Everywhere
por: Iskander, Peter A, et al.
Publicado: (2023) -
Chambres à fils
Publicado: (1983)